Home Cart Sign in  
Chemical Structure| 342777-54-2 Chemical Structure| 342777-54-2

Structure of LM22B-10
CAS No.: 342777-54-2

Chemical Structure| 342777-54-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LM22B-10 is an agonist of TrkB and TrkC neurotrophin receptor. It can improve survival and increase neurite outgrowth in vitro.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LM22B-10

CAS No. :342777-54-2
Formula : C27H33ClN2O4
M.W : 485.01
SMILES Code : ClC1=CC=C(C(C2=CC=C(N(CCO)CCO)C=C2)C3=CC=C(N(CCO)CCO)C=C3)C=C1
MDL No. :MFCD00483554
InChI Key :QCXQLSGBOUUVNH-UHFFFAOYSA-N
Pubchem ID :542158

Safety of LM22B-10

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Related Pathways of LM22B-10

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow macrophages (BMMs) 30 μM 3 days Evaluate the inhibitory effect of MRL on mitochondrial function PMC10664306
Bone marrow macrophages (BMMs) 30 μM 7 days Evaluate the inhibitory effect of MRL on osteoclast differentiation PMC10664306
MDA-MB-231 cells 50 µM 48 hours Reversed the inhibitory effects of HSP20 overexpression on cell proliferation and migration PMC9650602
NIH-3T3-TrkC cells 10 to 1000 nM 72 to 96 hours To assess the effect of BD10-2 on the survival of 3T3 cells expressing TrkC, results showed that BD10-2 promoted survival of 3T3-TrkC cells in a dose-dependent manner PMC11247716
NIH-3T3-TrkB cells 10 to 1000 nM 72 to 96 hours To assess the effect of BD10-2 on the survival of 3T3 cells expressing TrkB, results showed that BD10-2 promoted survival of 3T3-TrkB cells in a dose-dependent manner PMC11247716
786-O cells 5 mM LM22B-10, as an ERK activator, combined with miR-133b overexpression, weakened the anticancer effects of miR-133b. PMC7248518

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice APPL/S Mice model Oral gavage 50 mg/kg 5 days/week for 3 months To evaluate the effect of BD10-2 on memory and synaptic function in APPL/S mice, results showed that BD10-2 significantly improved memory and long-term potentiation (LTP) deficits and restored abnormalities in synapse-related signaling proteins PMC11247716
C57BL/6J mice Ovariectomy-induced osteoporosis model Intraperitoneal injection 30 mg/kg Once a week for 6 weeks Evaluate the therapeutic effect of MRL on osteoporosis PMC10664306
Nude mice PNI model Daily administration 50 mg/kg Once daily for 2 weeks To confirm the effects of MMP1 knockdown on PNI, results showed that LM22B-10 partially abolished the effects of MMP1 knockdown. PMC9701873

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.31mL

2.06mL

1.03mL

20.62mL

4.12mL

2.06mL

References

 

Historical Records

Categories